Efficacy of Information System Regarding the Consumption of Antibiotics and Bacterial Resistance in Primary Care

Efficacy of Information System Regarding the Consumption of Antibiotics and Bacterial Resistance on the Use of Antibiotics in Primary Care

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02816528

Acronym

SICAR-Amb

Enrollment

472

Registered

2016-06-28

Start date

2016-06-24

Completion date

2020-11-30

Last updated

2019-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease

Keywords

Antibiotics, Primary care, Stewardship, General practitioners

Brief summary

France is a country strong consumer of antibiotics in Europe, specially in primary care. Outpatient antibiotic use represents around 90% of total antibiotic use and prescriptions come mainly from general practitioners. A literature review of antibiotic stewardship in primary care show that there is no evaluation of interest of giving information about consumption of antibiotics and bacterial resistance to general practitioners. The objective of this study is to demonstrate that practitioners implicated in the followed of consumption of antibiotics and bacterial resistance around their geographical area of practice could change and improve their practices in good use of antibiotics.

Interventions

BEHAVIORALTraining program

Physicians will be given informations regarding antibiotic consumptions and bacterial resistance in their activity area every 3 months during 12 months.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* General practitioners in a Meurthe-et-Moselle french department

Exclusion criteria

* General practitioners out of Meurthe-et-Moselle french department

Design outcomes

Primary

Measure	Time frame	Description
Consumption of antibiotics	36 months	Antibiotics consumptions are provided by CNAMTS and calculated in defined daily dose DDD/1000 patient-days around the geographical area concerned by this study.

Secondary

Measure	Time frame	Description
Bacterial resistance of Escherichia coli and Staphylococcus aureus	36 months	The number of intermediate and resistant strains of E.coli and S.aureus are provided by MedQual around the geographical area concerned by this study.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026